Prodesse Inc. of Waukesha, Wis., and Invitrogen Corp. of Carlsbad, Calif., have signed a licensing agreement for diagnostic assays that incorporate the latter company’s Lux technology, reagents used in gene expression studies, biomarker analysis and functional genomics experiments. The arrangement will use Prodesse’s distribution capabilities to bring the technology to new market segments.